FLRG Fidelity U.S. Multifactor ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| NVDA | 6.75% |
| AAPL | 6.14% |
| GOOGL | 4.81% |
| MSFT | 4.54% |
| AVGO | 2.48% |
| XOM | 2.13% |
| META | 2.05% |
| JNJ | 1.72% |
| CF | 1.65% |
| V | 1.62% |
ETF Analysis
Fund Overview
Fidelity U.S. Multifactor ETF (FLRG) currently reports 99 stock positions (subject to change), placing it in the moderately broad range by holdings breadth. The top line-up is NVDA (6.75%), AAPL (6.14%), GOOGL (4.81%), with NVDA as the largest single weight at 6.75%. Together, the top three holdings account for 17.70%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.
Profitability & Capital Efficiency
Looking at how effectively the underlying holdings deploy capital, ROIC is 38.08%, WACC is 8.72%, and the economic spread is 29.37%. On balance, holdings are earning returns on capital well in excess of what investors and creditors require — the defining characteristic of a high-quality compounding portfolio. Supporting metrics show ROE at 51.23% and ROA at 14.64%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
On an earnings multiple basis, trailing P/E of 19.89, forward P/E of 16.21, PEG of 1.92. The gap between trailing and forward multiples is not especially wide, suggesting the market is pricing a steadier earnings path rather than a sharp near-term re-rating. The PEG ratio sits in a range that most investors would consider fair — neither cheap nor obviously stretched relative to anticipated earnings. A current ratio reading of 2.10 points to holdings that are managing short-term obligations without apparent stress. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.
Margins & Cash Generation
Across the three margin layers, gross margin sits at 59.50%, operating margin at 34.43%, and free cash flow margin at 27.09%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. Operating margins this strong typically indicate a combination of pricing power, cost discipline, and operating leverage. Free cash flow conversion is exceptional, indicating holdings that are self-funding and cash-generative well above average. Read together, these margins describe businesses that have earned their profitability rather than manufactured it through accounting — a meaningful quality signal.
Growth & Forward Outlook
Two key indicators frame the near-term view: TTM revenue growth of 16.61% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 17.39%, where the target distribution indicates incremental upside rather than outsized repricing. The near-term return case is built on whether reported trends and analyst projections can remain close enough to make current prices look justified. Whether the setup resolves positively or negatively will depend as much on the macro backdrop as on the capacity of the underlying businesses to deliver against current estimates. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyThe full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.
The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.